Integrated Core Strategies (US) LLC 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-02 5:14 pm Purchase | 2026-05-26 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 3,850,385 5.500% | 1,231,790 (+47.04%) | Filing |
| 2026-02-11 5:10 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 2,618,595 4.600% | 717,010 (+37.71%) | Filing |
| 2025-10-27 4:32 pm Purchase | 2025-10-20 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 1,901,585 9.000% | 1,901,585 (New Position) | Filing |